Back to Agenda
European Regulatory Town Hall Meeting
Session Chair(s)
Ian Hudson
Senior Advisor, Integrated Development
Bill and Melinda Gates Foundation, United States
Guido Rasi, MD
Chairman,Clinical Trial Center of Gemelli Polyclinic Inst; Prof of Microbiology
Tor Vergata University of Rome, Italy
The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have adopted a common strategy to 2020 for the European medicines regulatory network, with joint key priorities and a high-level roadmap. Join with selected heads of national agencies and EMA to hear how the strategy will make a difference to human health in the EU to 2020. The audience will be asked to give live feedback through interactive voting on the themes and priorities of the strategy.
Speaker(s)
Klaus Cichutek, PhD
Paul-Ehrlich-Institut, Germany
Director
Panel Discussion
Emer Cooke, MBA, MSc
European Medicines Agency, Netherlands
Chair, ICMRA; Executive Director
Panel Discussion
Hugo Hurts
Medicines Evaluation Board (MEB), Netherlands
Chair HMA Brexit Task Force; Executive Director
Lorraine Nolan, PhD
Health Products Regulatory Authority , Ireland
Chief Executive
Panel Discusison
Bettina Ryll
MPNE, Vision Zero Cancer, Sweden
Member of the First EU Cancer Mission Board
Have an account?